. ELISA assay of CA19-9 in the supernatant of 10 pancreatic cancer cell lines Capan-1, CFPAC-1, BXPC-3, HPAF, PanC-1, AsPC-1, 766T, Capan-2, HPDE and SW1990: Capan-1 cells showed the highest expression of CA19-9 (*** p＜0.001 compared with other cell lines by One-way ANOVA and Tukey HSD, n=4). Figure S3 . CCK8 assay of capan-1 cells (A) 24 h and (B) 48 h under different UMMD conditions including 0.4w, 30s; 0.4w, 60s; 0.8w, 30s; 0.8w, 60s; 1.2w, 30s; 1.2w, 60s; 1.6w, 30s; 1.6w, 60s. Cell viability decreased in the last three groups, * p＜0.05, ** p＜0.01, *** p＜0.001 compared with the control group by One-way ANOVA and Tukey HSD, n=6. 0.8w, 60s and 1.2w, 30s were the proper conditions of UMMD. Figure S4 . Cellular uptake of RB-NP 8 h after application of UMMD at 0.8w, 60s and 1.2w, 30s: The scale bars represent 25μm. A relatively brighter fluorescence was observed with 1.2w, 30s than with 0.8w, 60s. Therefore, we selected 1.2w,30s as the final UMMD condition in vitro. Figure S5 . Determination of the appropriate UMMD conditions in vivo: The conditions tested were 0.4w, 0.8w, 1.2w, 1.6w and 2.0w for 5 minutes. (A) tumor growth curve, (B) tumor samples, and (C) tumor weight Data demonstrated that tumor progression was most inhibited at 1.6w and 2.0w. * p＜0.05 compared with the control group by Mann-Whitney U test, the p value of overall comparison was 0.029 by KruskalWallis test. Thus, we chose 1.2w,5min as the final UMMD condition for t in vivo experiments. Figure S6 . CCK8 assay of Capan-1 cells: (A) 24 h and (B) 48 h after incubation with different concentrations of blank NP and NP-Ab. One-way ANOVA and Tukey HSD were performed for statistical tests at every concentration. For 250μg/mL and 500μg/mL at 48 h, the overall p value was 0.045 and 0.048, respectively, but there was no significant difference in multiple comparison by Tukey HSD. 
